Skip to content

Schneider 8 Fr. Stamina Guiding Catheter

by Schneider Intl., Ltd.

510(k) K920157

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK920157 Date16 Mar 1992ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Schneider 8 Fr. Stamina(Tm) Guiding Catheter
510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Schneider 8 Fr. Stamina Guiding Catheter is a guiding catheter designed for use in cardiovascular procedures. It facilitates the delivery and positioning of interventional devices, such as pacemaker leads, within the heart’s venous system, ensuring precise and stable placement during implantation or revision procedures.

This catheter is supplied sterile and intended for single-use. It is constructed with an 8 French lumen diameter and is compatible with MRI environments under specified conditions. Storage requires protection from extreme temperatures and mechanical damage. The device holds FDA 510(k) clearance under classification DXY and regulatory number 870.3610, adhering to cardiovascular interventional standards.

Other devices from Schneider Intl., Ltd.

See all devices from Schneider Intl., Ltd. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary use of the Schneider 8 Fr. Stamina Guiding Catheter in cardiovascular procedures?

    The Schneider 8 Fr. Stamina Guiding Catheter is designed to assist in the precise delivery and stable positioning of interventional devices, such as pacemaker leads, within the heart’s venous system. It is specifically intended for use during implantation or revision procedures to ensure accurate placement.

  • Is the Schneider 8 Fr. Stamina Guiding Catheter compatible with MRI environments, and if so, under what conditions?

    Yes, the catheter is explicitly stated to be compatible with MRI environments, though the exact conditions for compatibility are not detailed in the provided data. Always verify the manufacturer’s guidelines for specific MRI safety protocols before use.

  • How should the Schneider 8 Fr. Stamina Guiding Catheter be stored, and what precautions should be taken?

    The catheter must be stored while protected from extreme temperatures and mechanical damage. Since it is supplied sterile and intended for single-use, ensure it remains in its original packaging until ready for immediate use to maintain sterility and integrity.

  • Is this catheter reusable, or is it intended for single-use only?

    The Schneider 8 Fr. Stamina Guiding Catheter is explicitly labeled as intended for single-use only. This designation ensures patient safety and sterility, as reuse could compromise these critical factors.

  • What is the regulatory pathway for the FDA clearance of this device, and what classification does it fall under?

    The device holds FDA 510(k) clearance under classification DXY (product code) and regulatory number 870.3610, with a decision described as *Substantially Equivalent* to a predicate device. It was reviewed by the Cardiovascular (CV) Advisory Committee and received clearance on March 16, 1992, under the traditional 510(k) pathway.